A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study,...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6d2c8ea5b86f45f8b7047596e82833d9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6d2c8ea5b86f45f8b7047596e82833d92021-11-30T16:27:05ZA Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA1663-981210.3389/fphar.2021.750959https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.750959/fullhttps://doaj.org/toc/1663-9812Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study, we argue that the susceptibility to epigenetic changes governing molecular cross talks along the BMP and PI3K/Akt pathway may underline how genetic background dictate GC-induced bone loss. Concordantly, osteoblasts from BALB/c or C57BL/6 neonatal mice were treated with dexamethasone for transcriptome profiling. Furthermore, we also confirmed that GC-pre-conditioned mesenchymal stem cells (MSCs) would give rise to defective osteogenesis by instigating epigenetic changes which affected the accessibility of enhancer marks. In line with these epigenetic changes, we propose that GC modulates a key regulatory network involving the scavenger receptor Cd36 in osteoblasts pre-conditioning pharmacological idiosyncrasy in GIO.Li LuYanzhen CaiXiaoling LuoZhangting WangSin Hang FungHuanhuan JiaHuanhuan JiaChi Lam YuWai Yee ChanKai Kei MiuWende XiaoFrontiers Media S.A.articleglucocorticoidglucocorticoid-induced osteoporosisbone lossbone morphogenetic protein signaling pathwayosteoblasts differentiationcis-expression quantitative trait lociTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glucocorticoid glucocorticoid-induced osteoporosis bone loss bone morphogenetic protein signaling pathway osteoblasts differentiation cis-expression quantitative trait loci Therapeutics. Pharmacology RM1-950 |
spellingShingle |
glucocorticoid glucocorticoid-induced osteoporosis bone loss bone morphogenetic protein signaling pathway osteoblasts differentiation cis-expression quantitative trait loci Therapeutics. Pharmacology RM1-950 Li Lu Yanzhen Cai Xiaoling Luo Zhangting Wang Sin Hang Fung Huanhuan Jia Huanhuan Jia Chi Lam Yu Wai Yee Chan Kai Kei Miu Wende Xiao A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
description |
Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study, we argue that the susceptibility to epigenetic changes governing molecular cross talks along the BMP and PI3K/Akt pathway may underline how genetic background dictate GC-induced bone loss. Concordantly, osteoblasts from BALB/c or C57BL/6 neonatal mice were treated with dexamethasone for transcriptome profiling. Furthermore, we also confirmed that GC-pre-conditioned mesenchymal stem cells (MSCs) would give rise to defective osteogenesis by instigating epigenetic changes which affected the accessibility of enhancer marks. In line with these epigenetic changes, we propose that GC modulates a key regulatory network involving the scavenger receptor Cd36 in osteoblasts pre-conditioning pharmacological idiosyncrasy in GIO. |
format |
article |
author |
Li Lu Yanzhen Cai Xiaoling Luo Zhangting Wang Sin Hang Fung Huanhuan Jia Huanhuan Jia Chi Lam Yu Wai Yee Chan Kai Kei Miu Wende Xiao |
author_facet |
Li Lu Yanzhen Cai Xiaoling Luo Zhangting Wang Sin Hang Fung Huanhuan Jia Huanhuan Jia Chi Lam Yu Wai Yee Chan Kai Kei Miu Wende Xiao |
author_sort |
Li Lu |
title |
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
title_short |
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
title_full |
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
title_fullStr |
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
title_full_unstemmed |
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA |
title_sort |
core omnigenic non-coding trait governing dex-induced osteoporotic effects identified without dexa |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d9 |
work_keys_str_mv |
AT lilu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT yanzhencai acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT xiaolingluo acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT zhangtingwang acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT sinhangfung acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT huanhuanjia acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT huanhuanjia acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT chilamyu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT waiyeechan acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT kaikeimiu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT wendexiao acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT lilu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT yanzhencai coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT xiaolingluo coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT zhangtingwang coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT sinhangfung coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT huanhuanjia coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT huanhuanjia coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT chilamyu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT waiyeechan coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT kaikeimiu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa AT wendexiao coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa |
_version_ |
1718406448751312896 |